Benzinga Pro
Marketfy
Financial Data & APIs
Events
Premarket Prep
Membership is Free
What are you waiting for? Sign up now!
Name:
Username available!
Username taken!
Email:
Email available!
Email taken!
Password:
Leave blank:
OR
Free Account Login
Click here to access your premium account
Username or email:
Password:
OR
Forgot password?
Contribute
Login
Join
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
Global Economics
Previews
Reviews
Small-Cap
Cryptocurrency
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Tech
Start-Ups
Fintech
Investing
Best Online Brokers
Personal Finance
Compare Brokers
TD Ameritrade Review
Ally Invest Review
Etrade Review
Personal Capital Review
Tradestation Review
Forex Review
Binary Options Review
Premium
Market Overview
Tickers
Articles
Keywords
Search by keyword...
googlecse
WANT TO CATCH
ACET
NEWS
BEFORE
IT CHANGES THE STOCK PRICE?
More From ACET
Summary
Ideas
Twitter ($ACET)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
Aceto Corporation
ACET
:NASDAQ
Add to Watchlist +
{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
1.467
-0.023 (-1.52%)
Data as of Dec 11, 2018
Prev. Close
1.49
Price Open
1.48
Volume
55,168
Day's Range
1.46 - 1.53
52 Wk Range
1.45 - 11.98
50 Day Moving Avg.
1.98
PE Ratio
0
Shares Outstanding
30.77M
Market Cap
45.53M
Trade ACET stock with
recommended broker Ally Invest
. Commissions as low as $3.95.
1d
5d
1m
3m
1y
5y
YTD
Analyst Rating
View All Ratings
Date
Research Firm
Action
Current
Target
4/19/18
Canaccord Genuity
Downgrades
Buy
Sell
11/06/17
Canaccord Genuity
Maintains
Buy
13.0
8/28/17
Canaccord Genuity
Maintains
Buy
15.0
Headlines
Press Releases
85 Biggest Movers From Friday
Lisa Levin
Mon, 12 Nov 2018 05:16:18 -0500
68 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Fri, 09 Nov 2018 12:42:23 -0500
Stocks Which Set New 52-Week Low Yesterday, Thurs., Nov. 8, 2018
Benzinga Newsdesk
Fri, 09 Nov 2018 09:38:53 -0500
Aceto shares fall 23.6% premarket after the company missed Q3 EPS and sales estimates.
Benzinga Newsdesk
Fri, 09 Nov 2018 09:19:11 -0500
Aceto Q1 EPS $(0.59) Misses $(0.05) Estimate, Sales $164.405M Miss $166.2M Estimate
Benzinga Newsdesk
Thu, 08 Nov 2018 17:30:41 -0500
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018
Benzinga Newsdesk
Thu, 08 Nov 2018 10:52:57 -0500
Stocks Which Set New 52-Week Low Friday, October 26th
Benzinga Newsdesk
Mon, 29 Oct 2018 08:56:33 -0500
Stocks Which Set New 52-Week Low Yesterday, October 23rd
Benzinga Newsdesk
Wed, 24 Oct 2018 09:06:57 -0500
Stocks Which Set New 52-Week Low Yesterday, October 22nd
Benzinga Newsdesk
Tue, 23 Oct 2018 08:54:01 -0500
The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results
Shanthi Rexaline
Fri, 28 Sep 2018 07:10:46 -0500
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
ACETO Reports Fiscal 2019 First Quarter Results
Globe Newswire
Nov 08, 2018
ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits
Globe Newswire
Nov 05, 2018
ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits
Globe Newswire
Nov 05, 2018
Analysis: Positioning to Benefit within Pattern Energy Group, Ollie's Bargain Outlet, Devon Energy, Aceto, The KEYW Holding, and Healthcare Services Group — Research Highlights Growth, Revenue, and Consolidated Results
Globe Newswire
Oct 29, 2018
ACETO Corporation Schedules First Quarter & Fiscal 2019 Financial Results News Release and Conference Call
Globe Newswire
Oct 22, 2018
Robbins Arroyo LLP: Aceto Corporation (ACET) Misled Shareholders According to a Recent Lawsuit
Business Wire
Oct 19, 2018
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Aceto Corporation (ACET) and Encourages ACET Investors to Contact the Firm
Globe Newswire
Oct 08, 2018
Aceto Investigation: Bernstein Liebhard LLP Announces Investigation Of Aceto Corporation - ACET
PRNewswire
Sep 28, 2018
ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results
Globe Newswire
Sep 28, 2018
Rollins Set to Join S&P 500; Inogen to Join S&P MidCap 400; Vanda Pharmaceuticals and Garrett Motion to Join S&P SmallCap 600
PRNewswire
Sep 25, 2018
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Partner Headlines
Generics under pressure on expanded price-fixing investigation
Seeking Alpha
23 hours ago
Aceto Corp. (ACET) CEO Bill Kennally on Q1 2019 Results - Earnings Call Transcript
Seeking Alpha
Nov 10, 2018
Aceto Corporation 2019 Q1 - Results - Earnings Call Slides
Seeking Alpha
Nov 09, 2018
Aceto misses by $0.15, beats on revenue
Seeking Alpha
Nov 08, 2018
Energy shares trade low on high crude prices and pipeline constraints, while commodities provide some cushion to Energy/Materials sector
Seeking Alpha
Oct 29, 2018
ACETO Corporation Schedules First Quarter & Fiscal —…–9 Financial Results News ...
GuruFocus
Oct 22, 2018
Aceto files for $200M mixed shelf offering
Seeking Alpha
Oct 20, 2018
FDA issues new guidance for developers of complex generics
Seeking Alpha
Oct 09, 2018
Generics in the green following proposed favorable guidance from FDA
Seeking Alpha
Oct 02, 2018
Aceto Corporation (ACET) CEO William Kennally on Q4 2018 Results - Earnings Call Transcript
Seeking Alpha
Sep 28, 2018
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
News Sentiment
Powered by StockSnips
Now:
Bearish
63.52% Positive
Earnings
View Earnings
Q1 2019
EST
Actual
Surprise
EPS:
-0.05
-0.59
-0.54
Rev:
166.20M
164.41M
-1.80M
Q2 2019
EST
Actual
Surprise
EPS:
Expected
2019-01-31
Rev:
WILL
ACET
SPIKE ON TOMORROW'S NEWS?
Stocks like
ACET
are creating awesome opportunities based on catalysts in the news. Is
ACET
the next one to get some major price action?
Create a Benzinga Pro account today to find out.
Company Profile
Read More
Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals.
Visit company website
Brokerage Center
Compare All Online Brokerages
Benzinga - Feed Your Mind
try pro
News
Markets
Ratings
Ideas
Tech
Small-Cap
Personal Finance
Premium Products
